Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide

R D Delmanto1, P L de Lima, M M Sugui

  • 1Departamento de Patologia, Faculdade de Medicina, UNESP, 18618-000, SP, Botucatu, Brazil.

Mutation Research
|September 12, 2001
PubMed

Insights

Agaricus blazei Murrill mushroom extracts demonstrated antimutagenic properties in vivo. A mixture of mushroom lineages inhibited cyclophosphamide-induced micronuclei formation in mice, suggesting a role in cancer prevention.

Area of Science:

  • Mycology
  • Toxicology
  • Immunology

Background:

  • Agaricus blazei Murrill extracts show anticarcinogenic and antimutagenic potential.
  • Antimutagenic activity may contribute to the anticarcinogenic effects of A. blazei, alongside immune system modulation.

Purpose of the Study:

  • To investigate the in vivo antimutagenic effect of A. blazei.
  • To evaluate the impact of A. blazei on cyclophosphamide (CP)-induced clastogenicity in mice.

Main Methods:

  • Male Swiss mice were treated with cyclophosphamide (CP) alone or with CP plus A. blazei mushroom solution at varying temperatures (4, 21, 60°C).
  • The micronucleus test in bone marrow (MNPCE) and peripheral blood (MNRET) was used to assess clastogenicity.

Main Results:

  • An aqueous solution of a mixture of A. blazei lineages inhibited CP-induced micronuclei formation in both bone marrow and peripheral blood.
  • A single isolated lineage of A. blazei did not reduce CP-induced micronuclei frequencies.

Conclusions:

  • A. blazei exhibits in vivo antimutagenic activity, particularly when using a mixture of lineages.
  • This antimutagenic effect may contribute to the observed anticarcinogenic properties of A. blazei under specific conditions.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).